Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

44 structures for P19447

Entry ID Method Resolution Chain Position Source
4ERN X-ray 180 A A 494-782 PDB
5IVW EM 1000 A V 1-782 PDB
5IY6 EM 720 A V 1-782 PDB
5IY7 EM 860 A V 1-782 PDB
5IY8 EM 790 A V 1-782 PDB
5IY9 EM 630 A V 1-782 PDB
5OF4 EM 440 A A 265-782 PDB
6NMI EM 370 A A 34-730 PDB
6O9L EM 720 A 7 1-782 PDB
6O9M EM 440 A 7 1-782 PDB
6RO4 EM 350 A A 1-782 PDB
7AD8 EM 350 A A 1-782 PDB
7EGB EM 330 A 6 1-782 PDB
7EGC EM 390 A 6 1-782 PDB
7ENA EM 407 A 6 1-782 PDB
7ENC EM 413 A 6 1-782 PDB
7LBM EM 480 A W 1-782 PDB
7NVR EM 450 A 7 1-782 PDB
7NVV EM 290 A 7 1-782 PDB
7NVW EM 430 A 7 1-782 PDB
7NVX EM 390 A 7 1-782 PDB
7NVY EM 730 A 7 1-782 PDB
7NVZ EM 720 A 7 1-782 PDB
7NW0 EM 660 A 7 1-782 PDB
8BVW EM 400 A 0 1-772 PDB
8BYQ EM 410 A 0 1-782 PDB
8EBS EM 400 A A 1-782 PDB
8EBT EM 390 A A 52-721 PDB
8EBU EM 330 A A 1-782 PDB
8EBV EM 710 A A 1-782 PDB
8EBW EM 560 A A 1-782 PDB
8EBX EM 360 A A 1-782 PDB
8EBY EM 360 A A 1-782 PDB
8GXQ EM 504 A HH 1-782 PDB
8GXS EM 416 A HH 1-782 PDB
8WAK EM 547 A 6 1-782 PDB
8WAL EM 852 A 6 1-782 PDB
8WAN EM 607 A 6 1-782 PDB
8WAO EM 640 A 6 1-782 PDB
8WAP EM 585 A 6 1-782 PDB
8WAQ EM 629 A 6 1-782 PDB
8WAR EM 720 A 6 1-782 PDB
8WAS EM 613 A 6 1-782 PDB
AF-P19447-F1 Predicted AlphaFoldDB

620 variants for P19447

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV002505598
RCV001051064
rs199934696
CA1858638
11 K>R Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV002556852
RCV002558280
rs771345526
CA1858615
RCV001133123
44 K>R Xeroderma pigmentosum group B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV002491401
RCV002258141
rs149309991
RCV001873529
CA1858611
RCV001133122
48 E>D Xeroderma pigmentosum Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001850776
RCV000287017
rs767507847
CA1858579
85 F>C Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
VAR_003632
CA257543
RCV000018051
rs121913045
99 F>S Xeroderma pigmentosum group B XP-B; combined with features of Cockayne syndrome; mild [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
rs116713511
RCV001308354
RCV002258139
RCV001132192
CA1858570
105 E>G Xeroderma pigmentosum Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV002487171
CA090899
RCV000986812
rs34295337
RCV000255849
RCV001175535
109 R>* Xeroderma pigmentosum Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA126690
RCV000018052
VAR_008186
rs121913046
119 T>P Trichothiodystrophy 2, photosensitive TTD2; mild [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV002523084
CA1858562
RCV001294155
rs370115857
RCV000345555
RCV001859963
120 A>V Trichothiodystrophy 2, photosensitive Xeroderma pigmentosum group B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV002256209
RCV000290626
CA1858557
RCV002521284
rs145762413
RCV001859962
RCV001828326
129 V>I Xeroderma pigmentosum Trichothiodystrophy 2, photosensitive Xeroderma pigmentosum group B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000986811
CA348391475
RCV001858655
rs1404293670
154 Q>* Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
CA1858513
COSM1399212
rs139690693
RCV001132191
RCV002556844
177 V>I Variant assessed as Somatic; 0.0 impact. large_intestine Xeroderma pigmentosum group B [NCI-TCGA, Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV000770819
CA1858507
rs138385061
RCV002536615
195 R>* Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000778562
rs1558962530
266 Q>missing Xeroderma pigmentosum group B [ClinVar] Yes ClinVar
dbSNP
RCV000018054
RCV002513093
rs866379139
269 S>* Xeroderma pigmentosum group B [ClinVar] Yes ClinVar
dbSNP
CA248735
RCV002257425
RCV001129472
RCV001362006
RCV001294157
RCV000120800
rs145201970
RCV000765502
283 R>C Trichothiodystrophy 2, photosensitive Xeroderma pigmentosum Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001129471
RCV001856686
rs370519739
CA1858360
359 K>R Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA1858359
COSM280850
RCV000373572
rs754010782
RCV001372395
360 R>C Variant assessed as Somatic; 0.0 impact. large_intestine Xeroderma pigmentosum group B [NCI-TCGA, Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV000358594
CA1858341
rs374264195
386 D>N Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA257545
RCV002513092
rs121913047
RCV000018053
RCV001851900
425 R>* Xeroderma pigmentosum group B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1573957226
RCV000991968
CA348389589
RCV001766807
431 K>Q Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001136452
CA1858272
rs371627165
RCV001301220
471 V>I Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV002255296
RCV000018055
RCV000120802
RCV002477310
rs587778281
RCV000482017
474 D>missing Xeroderma pigmentosum Xeroderma pigmentosum group B [ClinVar] Yes ClinVar
dbSNP
RCV000018056
CA257548
rs121913048
545 Q>* Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001766813
rs1474396878
RCV000997198
CA348388340
567 A>V Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV000779279
RCV001856170
rs774261851
586 Q>missing Xeroderma pigmentosum group B [ClinVar] Yes ClinVar
dbSNP
RCV001090271
RCV002482161
rs770925947
588 E>missing Xeroderma pigmentosum group B [ClinVar] Yes ClinVar
dbSNP
RCV000779278
rs1558952235
630 G>missing Xeroderma pigmentosum group B [ClinVar] Yes ClinVar
dbSNP
rs1404157087
CA348387004
RCV000986806
645 R>* Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV002258798
rs568193912
RCV000120790
RCV001462857
CA158821
654 E>K Xeroderma pigmentosum [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
dbSNP
gnomAD
CA158824
rs587778275
RCV001788035
RCV000120791
RCV002515857
RCV001854617
COSM1325944
666 D>N ovary Variant assessed as Somatic; 0.0 impact. Trichothiodystrophy 2, photosensitive Inborn genetic diseases [Cosmic, NCI-TCGA, ClinVar] Yes ClinGen
cosmic curated
ClinVar
ExAC
NCI-TCGA
dbSNP
gnomAD
CA1858091
RCV001133016
rs151216904
694 A>S Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs151216904
RCV001366056
RCV002256208
CA1858090
RCV000404854
COSM94239
694 A>T ovary Xeroderma pigmentosum Xeroderma pigmentosum group B [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs201806429
RCV002258140
RCV001873528
CA1858086
RCV001133015
696 M>R Xeroderma pigmentosum Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000339981
rs563550613
CA1858082
RCV001338905
702 A>V Xeroderma pigmentosum [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000861013
RCV000120792
RCV000986805
VAR_017294
RCV002257424
rs4150521
CA158827
704 S>L Xeroderma pigmentosum Xeroderma pigmentosum group B [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001132080
rs368664230
CA1858033
RCV001856706
742 R>W Variant assessed as Somatic; 0.0 impact. Xeroderma pigmentosum group B [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs1684056933
RCV002543833
RCV001321907
762 H>R Inborn genetic diseases [ClinVar] Yes ClinVar
dbSNP
rs866954274
CA55344414
2 G>D No ClinGen
Ensembl
rs1028560626
CA55344388
3 K>R No ClinGen
TOPMed
gnomAD
rs1394007429
CA348392480
4 R>S No ClinGen
TOPMed
CA1858702
rs542029381
6 R>* No ClinGen
1000Genomes
ExAC
gnomAD
CA55344367
rs893323064
6 R>P No ClinGen
TOPMed
gnomAD
rs893323064
CA348392469
6 R>Q No ClinGen
TOPMed
gnomAD
rs1461005787
CA348392462
7 A>V No ClinGen
gnomAD
rs756810937
CA1858701
8 D>N No ClinGen
ExAC
gnomAD
CA348392454
rs1319949323
9 R>S No ClinGen
gnomAD
CA348392446
rs1438418977
10 D>N No ClinGen
gnomAD
rs199934696
RCV001051065
11 K>M No ClinVar
dbSNP
CA1858637
rs746412466
11 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs1032532070
CA55343771
12 K>R No ClinGen
Ensembl
rs1454594744
CA348392402
15 R>W No ClinGen
gnomAD
rs779316093
CA348392388
17 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA1858635
rs771417265
17 R>L No ClinGen
ExAC
gnomAD
rs749337980
CA1858634
18 H>P No ClinGen
ExAC
gnomAD
rs756471066
CA1858632
22 E>G No ClinGen
ExAC
gnomAD
CA1858630
rs531561069
24 D>E No ClinGen
1000Genomes
ExAC
rs1313189867
CA348392333
24 D>G No ClinGen
TOPMed
gnomAD
CA1858631
rs752952963
24 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA348392334
rs1313189867
24 D>V No ClinGen
TOPMed
gnomAD
TCGA novel 27 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs144596821
CA55343711
27 E>K No ClinGen
ESP
ExAC
gnomAD
rs144596821
CA1858628
27 E>Q No ClinGen
ESP
ExAC
gnomAD
rs562762727
CA55343684
29 A>V No ClinGen
1000Genomes
CA1858625
rs751320999
30 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA348392293
rs1371919188
30 P>L No ClinGen
gnomAD
TCGA novel 30 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA55343666
rs907355401
33 D>E No ClinGen
TOPMed
rs1373227745
CA348392257
35 Q>H No ClinGen
gnomAD
CA348392261
rs1250589018
35 Q>K No ClinGen
TOPMed
CA1858623
rs773797861
37 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA348392243
rs1435070019
37 A>V No ClinGen
gnomAD
rs897871697
CA55343634
39 P>H No ClinGen
Ensembl
CA348392226
rs1251238422
40 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA348392220
rs1239018301
41 A>V No ClinGen
TOPMed
CA1858618
rs759837409
42 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs776237342
CA1858619
42 A>T No ClinGen
ExAC
gnomAD
CA1858617
rs759837409
42 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs749797540
CA1858614
45 Q>L No ClinGen
ExAC
TOPMed
gnomAD
rs1054769172
CA55343586
46 V>A No ClinGen
TOPMed
gnomAD
CA348392193
rs1054769172
46 V>G No ClinGen
TOPMed
gnomAD
rs777771292
CA1858613
47 D>V No ClinGen
ExAC
gnomAD
TCGA novel 47 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1858612
rs769971648
48 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA55343559
rs759337466
50 G>D No ClinGen
Ensembl
CA348392166
rs1353065985
51 T>A No ClinGen
TOPMed
gnomAD
CA1858610
rs781589410
53 V>A No ClinGen
ExAC
gnomAD
TCGA novel 55 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA158839
rs587778277
RCV000120796
58 A>T No ClinGen
ClinVar
Ensembl
dbSNP
CA1858608
rs577213973
58 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs758329360
CA1858606
61 Y>C No ClinGen
ExAC
gnomAD
rs1412591056
CA348392089
62 R>K No ClinGen
gnomAD
rs764770312
CA1858604
63 L>M No ClinGen
ExAC
gnomAD
rs1439555872
CA348392058
66 P>L No ClinGen
TOPMed
rs1279830695
CA348392029
70 D>E No ClinGen
gnomAD
rs377255867
CA348392027
71 H>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 71 H>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1258618385
CA348392025
71 H>R No ClinGen
gnomAD
rs377255867
CA1858602
71 H>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348392020
rs1558965389
72 T>A No ClinGen
Ensembl
rs763746043
CA348392017
72 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs763746043
CA1858601
72 T>N No ClinGen
ExAC
TOPMed
gnomAD
CA1858598
rs553774995
75 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1858599
rs774644406
75 P>T No ClinGen
ExAC
gnomAD
rs201635630
CA1858597
77 W>C No ClinGen
1000Genomes
ExAC
gnomAD
rs1341880081
CA348391982
78 V>G No ClinGen
gnomAD
rs1244964997
CA348391984
78 V>L No ClinGen
gnomAD
CA348391964
rs1391088981
79 A>V No ClinGen
gnomAD
CA55342976
rs1046333193
81 D>E No ClinGen
Ensembl
CA348391955
rs1453017999
81 D>N No ClinGen
gnomAD
rs1246605943
CA348391945
82 G>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs532415974
CA348391939
83 H>P No ClinGen
1000Genomes
TOPMed
CA55342958
rs532415974
83 H>R No ClinGen
1000Genomes
TOPMed
rs1013443416
CA55342953
84 I>S No ClinGen
Ensembl
rs1200235000
CA348391928
85 F>L No ClinGen
gnomAD
rs773655670
CA1858578
87 E>G No ClinGen
ExAC
gnomAD
CA1858576
rs762406830
88 A>V No ClinGen
ExAC
gnomAD
CA55342947
rs1004141219
89 F>V No ClinGen
TOPMed
gnomAD
rs1275332128
CA348391892
90 S>C No ClinGen
gnomAD
rs1438551749
CA348391889
91 P>A No ClinGen
TOPMed
gnomAD
rs776911903
CA1858574
91 P>L No ClinGen
ExAC
gnomAD
CA348391888
rs1438551749
91 P>S No ClinGen
TOPMed
gnomAD
rs768763299
CA348391878
93 Y>H No ClinGen
ExAC
TOPMed
gnomAD
rs768763299
CA1858573
93 Y>N No ClinGen
ExAC
TOPMed
gnomAD
rs1371373080
CA348391867
94 K>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 94 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348391804
rs1311592942
103 I>T No ClinGen
TOPMed
CA158842
rs587778278
RCV000120797
103 I>V No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA348391801
rs1479291031
104 A>T No ClinGen
gnomAD
rs201698871
CA348391790
105 E>D No ClinGen
TOPMed
gnomAD
CA1858568
rs757248927
108 C>G No ClinGen
ExAC
gnomAD
rs755616510
CA348391765
109 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA1858566
rs755616510
109 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1348437205
CA348391757
111 T>A No ClinGen
gnomAD
rs1287985700
CA348391748
112 H>R No ClinGen
TOPMed
CA348391750
rs1363688604
112 H>Y No ClinGen
Ensembl
TCGA novel 113 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348391735
rs1278935659
114 H>P No ClinGen
TOPMed
gnomAD
CA348391734
rs1278935659
114 H>R No ClinGen
TOPMed
gnomAD
CA1858564
rs767213626
115 E>D No ClinGen
ExAC
gnomAD
CA1858563
rs754522317
116 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA55342861
rs762430357
117 K>N No ClinGen
TOPMed
gnomAD
CA158845
VAR_014766
RCV001854620
rs1805161
RCV000120798
117 K>R No ClinGen
ClinVar
UniProt
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs775162343
CA55342849
118 L>V No ClinGen
Ensembl
rs1358876899
CA348391702
119 T>N No ClinGen
gnomAD
COSM3836746
rs1406400169
CA348391662
125 A>V Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA55342811
rs560809471
126 A>S No ClinGen
1000Genomes
ExAC
gnomAD
rs560809471
CA1858560
126 A>T No ClinGen
1000Genomes
ExAC
gnomAD
rs1472612465
CA348391657
127 V>I No ClinGen
gnomAD
CA348391640
rs1315300796
129 V>A No ClinGen
TOPMed
rs145762413
CA348391643
129 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348391638
rs1237762253
130 G>R No ClinGen
gnomAD
rs1211945316
CA348391633
130 G>V No ClinGen
gnomAD
CA1858556
rs772341214
134 S>G No ClinGen
ExAC
gnomAD
CA1858555
rs759746188
137 T>A No ClinGen
ExAC
gnomAD
rs773390535
CA1858552
138 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1209294822
CA348391569
140 L>F No ClinGen
TOPMed
rs749261203
CA1858550
141 R>G No ClinGen
ExAC
gnomAD
CA348391563
rs1231600544
141 R>T No ClinGen
gnomAD
CA348391536
rs1378698993
145 K>E No ClinGen
gnomAD
rs1285060522
CA348391531
145 K>N No ClinGen
gnomAD
rs149781954
CA1858549
146 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs769561472
CA1858548
150 D>E No ClinGen
ExAC
gnomAD
CA348391502
rs1343838938
150 D>G No ClinGen
gnomAD
rs1390119570
CA348391489
152 I>T No ClinGen
gnomAD
rs1458243351
CA348391492
152 I>V No ClinGen
gnomAD
CA348391483
rs1162168898
153 M>R No ClinGen
gnomAD
TCGA novel 153 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348391477
rs1404293670
154 Q>K No ClinGen
gnomAD
rs376722014
CA1858547
154 Q>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348391461
rs1237725504
156 I>V No ClinGen
TOPMed
rs1207322794
CA348391428
158 L>F No ClinGen
TOPMed
CA348391412
rs1251030097
161 V>L No ClinGen
gnomAD
rs376925542
CA1858533
163 Y>C No ClinGen
ESP
ExAC
gnomAD
CA1858532
rs772817885
167 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA1858531
rs769839328
168 L>R No ClinGen
ExAC
TOPMed
gnomAD
CA1858530
rs775263112
173 N>S No ClinGen
ExAC
gnomAD
CA348391325
rs1220765207
174 R>G No ClinGen
TOPMed
CA348391321
rs1271441790
174 R>K No ClinGen
TOPMed
rs1360806711
CA348391302
175 Y>C No ClinGen
gnomAD
rs114994654
CA348391291
176 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 180 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348391250
rs1409899714
182 P>R No ClinGen
TOPMed
CA348391246
rs1478932651
183 D>H No ClinGen
TOPMed
gnomAD
rs140572401
CA1858512
184 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 185 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1183082780
CA348391221
186 Q>H No ClinGen
TOPMed
gnomAD
CA1858510
rs768670201
189 L>I No ClinGen
ExAC
gnomAD
rs144491407
CA1858508
193 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 194 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs751847283
CA55340638
194 I>V No ClinGen
Ensembl
rs138385061
CA1858506
195 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348391167
rs1467693328
195 R>Q No ClinGen
gnomAD
rs748503195
CA1858502
198 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA1858500
rs755418225
201 N>I No ClinGen
ExAC
gnomAD
rs755418225
CA1858501
201 N>S No ClinGen
ExAC
gnomAD
TCGA novel 202 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1396363819
CA348391118
202 S>F No ClinGen
gnomAD
TCGA novel 202 S>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 203 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1858499
rs751705179
204 G>E No ClinGen
ExAC
gnomAD
rs13427563
CA348391097
205 E>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1318391186
CA348391099
205 E>V No ClinGen
gnomAD
CA1858496
rs368953792
207 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1858495
rs765463072
208 E>A No ClinGen
ExAC
gnomAD
CA1858494
rs761537841
210 I>F No ClinGen
ExAC
gnomAD
CA1858493
rs776433788
210 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA348391062
rs1558962928
211 T>I No ClinGen
Ensembl
rs760681360
CA1858491
213 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1464840646
CA348391037
215 T>I No ClinGen
TOPMed
gnomAD
rs1337069381
CA348391031
216 S>N No ClinGen
gnomAD
rs374275821
CA1858488
219 A>T No ClinGen
ESP
ExAC
gnomAD
CA1858463
rs377665046
220 I>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1306451467
CA348390995
220 I>V No ClinGen
gnomAD
CA348390986
rs1167535533
221 S>F No ClinGen
gnomAD
rs1558962721
CA348390985
222 K>Q No ClinGen
Ensembl
rs780564758
CA1858462
223 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA1858461
rs772575791
225 E>K No ClinGen
ExAC
gnomAD
TCGA novel 226 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs587778279
CA55340084
228 G>C No ClinGen
ExAC
TOPMed
gnomAD
rs587778279
CA158848
RCV000120799
228 G>R No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1156498564
CA348390928
230 P>L No ClinGen
TOPMed
rs201383161
CA1858460
232 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA1858459
rs757474477
232 T>I No ClinGen
ExAC
gnomAD
CA55340065
rs980899348
234 R>* No ClinGen
TOPMed
CA348390909
rs1249110579
234 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 235 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754087195
CA1858458
240 G>D No ClinGen
ExAC
CA1858457
rs777749462
241 K>E No ClinGen
ExAC
TOPMed
gnomAD
rs1237231600
CA348390856
242 S>F No ClinGen
TOPMed
rs1191447900
CA348390860
242 S>P No ClinGen
TOPMed
gnomAD
CA348390851
rs1344200585
243 D>G No ClinGen
gnomAD
CA348390853
rs1198587049
243 D>Y No ClinGen
TOPMed
gnomAD
CA348390847
rs1453742922
244 I>L No ClinGen
TOPMed
gnomAD
rs752490818
CA1858455
245 P>S No ClinGen
ExAC
gnomAD
rs779588545
CA55340028
246 M>K No ClinGen
Ensembl
CA55340039
rs760816658
246 M>V No ClinGen
Ensembl
CA348390828
rs1573960935
247 D>N No ClinGen
Ensembl
rs1558962604
CA348390820
248 L>M No ClinGen
Ensembl
rs759450760
CA1858453
251 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA1858452
rs751088488
252 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA1858451
rs765891376
253 E>K No ClinGen
ExAC
gnomAD
CA55339940
rs755764533
254 Q>* No ClinGen
gnomAD
rs1413165197
CA348390775
254 Q>R No ClinGen
gnomAD
rs1402080984
CA348390770
255 M>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA55339933
rs1038911769
256 D>E No ClinGen
TOPMed
CA1858450
rs762635900
257 K>E No ClinGen
ExAC
gnomAD
rs772883177
CA1858449
259 E>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1472688612
CA348390687
265 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs769390355
CA1858444
267 T>I No ClinGen
ExAC
gnomAD
rs201622885
CA1858442
269 S>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 271 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1207731792
CA348390636
273 K>R No ClinGen
gnomAD
CA1858440
rs746369215
274 Q>H No ClinGen
ExAC
gnomAD
rs568770952
CA1858422
275 E>G No ClinGen
1000Genomes
ExAC
gnomAD
rs930132955
CA55339317
276 M>I No ClinGen
TOPMed
CA1858421
rs200443230
276 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA1858420
rs749390618
283 R>H No ClinGen
ExAC
gnomAD
rs773357279
CA1858419
COSM1399209
285 I>V large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1380889199
CA348390515
289 Y>N No ClinGen
gnomAD
CA348390505
rs1413335378
290 P>S No ClinGen
TOPMed
rs142304812
CA1858417
293 A>S No ClinGen
ESP
ExAC
gnomAD
CA1858416
rs142304812
293 A>T No ClinGen
ESP
ExAC
gnomAD
rs754834163
CA1858415
294 E>Q No ClinGen
ExAC
gnomAD
CA1858412
rs758268800
CA55339237
297 F>L No ClinGen
ExAC
gnomAD
CA1858413
rs145267069
297 F>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1858410
rs764717311
298 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA1858409
rs369840433
298 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs764717311
CA1858411
298 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs1340526199
CA348390454
299 N>D No ClinGen
gnomAD
CA1858408
rs753495508
301 S>A No ClinGen
ExAC
gnomAD
rs1363370930
CA348390417
304 P>H No ClinGen
gnomAD
TCGA novel 305 D>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348390405
rs1291272894
306 I>V No ClinGen
gnomAD
CA348390396
rs1435188738
307 N>T No ClinGen
gnomAD
CA1858403
rs779781754
310 L>I No ClinGen
ExAC
gnomAD
rs1277701138
CA348390360
312 P>L No ClinGen
gnomAD
rs763549081
CA1858401
312 P>S No ClinGen
ExAC
gnomAD
rs1423048236
CA348390324
318 P>L No ClinGen
TOPMed
gnomAD
rs1423048236
CA348390325
318 P>R No ClinGen
TOPMed
gnomAD
CA1858399
rs769963575
318 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA348390318
rs1189528251
319 Y>F No ClinGen
gnomAD
CA348390320
rs1189528251
319 Y>S No ClinGen
gnomAD
rs267598859
CA55339117
321 E>G No ClinGen
Ensembl
CA55339111
rs911067838
322 K>R No ClinGen
Ensembl
rs748138133
CA1858398
323 S>G No ClinGen
ExAC
gnomAD
rs776936481
CA1858397
323 S>T No ClinGen
ExAC
gnomAD
CA1858396
rs368191279
325 R>* No ClinGen
ESP
ExAC
gnomAD
CA1858395
COSM441077
rs746827111
325 R>Q Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA348390276
rs1205729889
326 K>E No ClinGen
gnomAD
CA348390270
rs779822517
326 K>N No ClinGen
ExAC
gnomAD
CA1858393
rs772058327
327 M>L No ClinGen
ExAC
gnomAD
CA348390267
rs772058327
327 M>V No ClinGen
ExAC
gnomAD
rs1218086016
CA348390242
330 N>S No ClinGen
gnomAD
rs745564603
CA55339057
331 G>R No ClinGen
TOPMed
CA1858390
rs756787161
332 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs1308398082
CA348390219
334 R>C No ClinGen
gnomAD
rs1463378560
CA348390218
334 R>H No ClinGen
TOPMed
gnomAD
CA1858389
rs142333442
335 S>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1558961958
CA348390191
339 V>I No ClinGen
Ensembl
rs1430093547
CA348390174
341 P>L No ClinGen
gnomAD
CA348390167
rs752026166
342 C>* No ClinGen
ExAC
TOPMed
gnomAD
rs138897577
CA348390164
343 G>C No ClinGen
ESP
TOPMed
gnomAD
CA55339028
rs138897577
343 G>S No ClinGen
ESP
TOPMed
gnomAD
rs1319634891
CA348390143
344 A>V No ClinGen
TOPMed
gnomAD
rs1384863160
CA348390127
347 S>P No ClinGen
gnomAD
rs1318493097
CA348390114
349 V>A No ClinGen
gnomAD
rs538080445
CA1858367
350 G>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1858366
rs374654628
350 G>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs780953436
CA1858364
353 A>P No ClinGen
ExAC
gnomAD
rs1558960995
CA348390090
354 A>T No ClinGen
Ensembl
TCGA novel 355 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348390075
rs1188002375
356 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA1858361
rs765846010
356 T>S No ClinGen
ExAC
gnomAD
rs764062606
CA1858358
360 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs775716891
CA348390044
361 C>F No ClinGen
ExAC
TOPMed
gnomAD
CA1858356
rs775716891
361 C>S No ClinGen
ExAC
TOPMed
gnomAD
rs775716891
CA1858357
361 C>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1573957723
CA348390031
363 V>G No ClinGen
Ensembl
CA1858355
rs772229792
365 G>D No ClinGen
ExAC
gnomAD
CA1858354
rs375440546
366 N>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1433368312
CA348390016
366 N>I No ClinGen
TOPMed
rs984881713
CA55337270
366 N>K No ClinGen
gnomAD
CA348389989
CA1858352
rs371109024
371 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs778865255
CA1858349
373 Q>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348389968
rs1327020283
374 W>R No ClinGen
gnomAD
CA1858347
rs747613438
COSM3713995
376 A>D upper_aerodigestive_tract [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1384044411
CA348389952
376 A>T No ClinGen
TOPMed
gnomAD
rs747613438
CA1858348
376 A>V No ClinGen
ExAC
gnomAD
CA1858346
rs781006740
377 Q>* No ClinGen
ExAC
gnomAD
rs754612702
CA1858345
379 K>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA348389922
rs1367864923
380 M>T No ClinGen
TOPMed
gnomAD
CA348389916
rs1167192463
381 W>R No ClinGen
gnomAD
rs1573957604
CA348389907
382 S>P No ClinGen
Ensembl
CA1858344
rs746303452
383 T>A No ClinGen
ExAC
gnomAD
rs1261030668
CA348389898
383 T>I No ClinGen
TOPMed
CA348389902
rs746303452
383 T>P No ClinGen
ExAC
gnomAD
rs1024820965
CA55337210
384 I>F No ClinGen
TOPMed
rs1573957583
CA348389895
384 I>N No ClinGen
Ensembl
TCGA novel 384 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348389888
rs1573957566
385 D>A No ClinGen
Ensembl
rs371396764
CA348389884
385 D>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA348389881
rs1573957547
386 D>A No ClinGen
Ensembl
CA1858340
rs147653814
387 S>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1402884340
CA348389874
387 S>N No ClinGen
TOPMed
CA348389868
rs1055129064
388 Q>* No ClinGen
TOPMed
gnomAD
CA55337199
rs1055129064
388 Q>E No ClinGen
TOPMed
gnomAD
rs370645943
CA55337196
388 Q>R No ClinGen
ESP
TOPMed
gnomAD
rs756167411
CA1858339
389 I>F No ClinGen
ExAC
gnomAD
CA55337191
rs1031196303
390 C>S No ClinGen
Ensembl
rs201840181
CA55337177
391 R>Q No ClinGen
Ensembl
rs1428334772
CA348389849
391 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA348389838
rs1573957485
393 T>P No ClinGen
Ensembl
rs775603873
CA55337144
395 D>H No ClinGen
Ensembl
CA1858337
rs767729262
396 A>G No ClinGen
ExAC
gnomAD
CA348389810
rs1329439780
397 K>R No ClinGen
gnomAD
rs1282822015
CA348389798
399 K>Q No ClinGen
gnomAD
TCGA novel 400 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1278381138
CA348389788
400 P>S No ClinGen
TOPMed
rs115176021
CA1858336
401 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
VAR_014767
rs1805162
CA1858334
402 G>C No ClinGen
UniProt
ExAC
TOPMed
dbSNP
gnomAD
rs1805162
CA1858333
402 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA55337118
rs773046382
403 C>W No ClinGen
ExAC
gnomAD
rs373790042
CA1858330
405 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs776274926
CA1858329
406 A>G No ClinGen
ExAC
rs1199596535
CA348389732
409 T>S No ClinGen
gnomAD
TCGA novel 410 Y>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1858328
rs768478601
412 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA1858327
rs746634537
413 L>P No ClinGen
ExAC
gnomAD
rs757589281
CA1858325
416 T>A No ClinGen
ExAC
gnomAD
rs974407309
CA55337084
416 T>I No ClinGen
TOPMed
rs1198677656
CA348389685
417 T>A No ClinGen
gnomAD
CA1858324
rs749619361
417 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA348389684
rs1198677656
417 T>S No ClinGen
gnomAD
VAR_035942 418 K>Q a breast cancer sample; somatic mutation [UniProt] No UniProt
TCGA novel 419 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1224268565
CA348389647
422 E>G No ClinGen
gnomAD
rs200098409
CA1858322
424 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA1858321
rs767573920
425 R>Q No ClinGen
ExAC
gnomAD
CA348389615
rs1175864176
427 M>I No ClinGen
TOPMed
CA348389596
rs1394793027
429 W>* No ClinGen
gnomAD
rs1394793027
CA348389597
429 W>C No ClinGen
gnomAD
rs1406068183
CA348389592
430 L>H No ClinGen
gnomAD
CA1858319
rs751701780
431 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1558960659
CA348389577
432 T>I No ClinGen
Ensembl
rs766583866
CA1858318
433 Q>K No ClinGen
ExAC
gnomAD
rs1434876636
CA348389568
434 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA1858317
rs762669491
435 W>R No ClinGen
ExAC
TOPMed
gnomAD
rs1352250300
CA348389539
438 M>L No ClinGen
TOPMed
rs1234401096
CA348389537
438 M>T No ClinGen
gnomAD
CA348389530
rs1188694467
439 I>F No ClinGen
TOPMed
gnomAD
CA1858315
rs772991846
439 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA348389531
rs1188694467
439 I>V No ClinGen
TOPMed
gnomAD
rs947992601
CA55337002
440 L>P No ClinGen
Ensembl
CA1858314
rs765152621
441 D>Y No ClinGen
ExAC
gnomAD
rs750263561
CA348389498
444 H>P No ClinGen
TOPMed
CA55336991
rs750263561
444 H>R No ClinGen
TOPMed
rs587778280
CA1858312
445 T>A No ClinGen
ExAC
TOPMed
gnomAD
RCV000120801
CA158851
rs587778280
RCV001854621
445 T>S No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs776211616
CA1858310
446 I>V No ClinGen
ExAC
gnomAD
rs115481013
CA1858283
449 K>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1573950396
CA348389448
450 M>I No ClinGen
Ensembl
TCGA novel 450 M>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1858282
rs200291162
450 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 451 F>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs150954655
CA1858281
COSM1006173
452 R>* Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs748473025
CA1858280
453 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs769083884
CA55332020
457 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1165306956
CA348389408
457 I>V No ClinGen
TOPMed
gnomAD
rs747124421
CA1858277
458 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA348389388
rs1413024779
460 A>S No ClinGen
TOPMed
rs1413024779
CA348389390
460 A>T No ClinGen
TOPMed
CA1858276
rs780167598
461 H>L No ClinGen
ExAC
gnomAD
rs758594852
CA348389376
462 C>G No ClinGen
ExAC
gnomAD
rs758594852
CA1858275
462 C>R No ClinGen
ExAC
gnomAD
TCGA novel 462 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1432845835
CA348389361
464 L>V No ClinGen
TOPMed
CA1858274
rs144012336
468 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1225262521
CA348389299
472 R>C No ClinGen
gnomAD
rs753633161
CA1858271
472 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1214609147
CA348389288
473 E>D No ClinGen
gnomAD
CA348389294
rs1369244363
473 E>K No ClinGen
TOPMed
CA55331967
rs554880985
474 D>N No ClinGen
1000Genomes
rs1363487714
CA348389256
478 V>M No ClinGen
gnomAD
TCGA novel 482 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs371767613
CA1858268
484 I>T No ClinGen
ESP
ExAC
gnomAD
rs759152503
CA1858266
486 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA348389187
rs1304706419
488 L>I No ClinGen
TOPMed
gnomAD
rs367552856
CA1858265
490 E>K No ClinGen
ESP
ExAC
gnomAD
CA1858264
rs765968359
492 N>S No ClinGen
ExAC
gnomAD
rs762169009
CA1858263
494 M>I No ClinGen
ExAC
gnomAD
CA348389142
rs1410547028
494 M>L No ClinGen
gnomAD
rs917709294
CA55331912
495 E>Q No ClinGen
gnomAD
CA55331892
rs558704941
498 N>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs373703862
CA1858261
498 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1858257
rs772222570
501 Y>* No ClinGen
ExAC
TOPMed
gnomAD
CA348389093
rs1251200118
501 Y>C No ClinGen
gnomAD
rs775470553
CA1858259
501 Y>H No ClinGen
ExAC
rs1309847812
CA348389085
502 I>N No ClinGen
gnomAD
CA1858256
rs745884071
503 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs539089848
CA1858254
506 Q>R No ClinGen
1000Genomes
ExAC
gnomAD
rs1233276309
CA348389034
508 A>T No ClinGen
TOPMed
CA348388907
rs1451873165
510 V>F No ClinGen
gnomAD
rs1359756987
CA348388843
514 M>I No ClinGen
TOPMed
rs755970243
CA1858231
RCV001325521
514 M>V No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs974005418
CA55331012
515 S>P No ClinGen
Ensembl
CA1858230
rs747849600
516 P>A No ClinGen
ExAC
gnomAD
CA348388826
rs747849600
516 P>S No ClinGen
ExAC
gnomAD
COSM1399204
CA1858229
rs781202683
517 E>K large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA348388781
rs1558956850
519 Y>S No ClinGen
Ensembl
rs148789293
CA1858228
520 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1034515602
CA55330986
520 R>Q No ClinGen
TOPMed
gnomAD
rs148789293
CA1858227
520 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs970240024
CA55330985
525 I>V No ClinGen
TOPMed
gnomAD
CA348388663
rs377662408
528 K>M No ClinGen
ESP
ExAC
gnomAD
CA1858225
rs377662408
528 K>R No ClinGen
ESP
ExAC
gnomAD
CA348388639
rs1302552127
COSM218645
RCV000997199
530 R>* pancreas [Cosmic] No ClinGen
cosmic curated
ClinVar
TOPMed
dbSNP
gnomAD
rs753534899
CA55330948
541 F>C No ClinGen
TOPMed
gnomAD
TCGA novel 543 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752934885
CA1858221
543 A>V No ClinGen
ExAC
gnomAD
rs1001657401
CA55330941
544 C>F No ClinGen
TOPMed
gnomAD
CA348388504
rs1001657401
544 C>Y No ClinGen
TOPMed
gnomAD
rs774624418
CA1858219
546 F>L No ClinGen
ExAC
gnomAD
CA348388488
rs1421835809
546 F>L No ClinGen
gnomAD
CA1858218
rs771107095
548 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA348388448
rs1295875856
552 E>G No ClinGen
TOPMed
gnomAD
rs768051277
CA55330892
553 R>K No ClinGen
Ensembl
rs1163407906
CA348388421
556 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA348388411
rs1445759342
557 K>R No ClinGen
gnomAD
CA348388400
rs773507392
559 I>L No ClinGen
ExAC
gnomAD
rs773507392
CA1858216
559 I>V No ClinGen
ExAC
gnomAD
rs747979985
CA1858214
567 A>S No ClinGen
ExAC
rs545926053
CA55330851
568 L>V No ClinGen
TOPMed
gnomAD
rs780835549
CA1858213
573 I>V No ClinGen
ExAC
gnomAD
rs768687646
CA1858212
574 R>* No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 574 R>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1858211
rs373218532
574 R>Q No ClinGen
ESP
ExAC
TOPMed
CA348388288
rs1361480597
576 N>S No ClinGen
TOPMed
gnomAD
rs1333192307
CA348387917
578 P>L No ClinGen
gnomAD
CA348387922
rs1405887613
578 P>S No ClinGen
gnomAD
rs745446062
CA1858188
579 Y>C No ClinGen
ExAC
CA348387896
rs147061557
581 Y>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs778277009
CA1858187
581 Y>C No ClinGen
ExAC
gnomAD
TCGA novel 581 Y>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348387893
rs1172169844
COSM203491
582 G>R large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA1858184
rs758238796
584 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs751916656
CA1858182
585 S>T No ClinGen
ExAC
gnomAD
CA348387864
rs1558953128
587 G>R No ClinGen
Ensembl
rs770925947 588 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348387842
rs1239997092
590 M>L No ClinGen
gnomAD
rs1200552239
CA348387832
591 Q>* No ClinGen
gnomAD
rs1460059364
CA348387828
591 Q>H No ClinGen
gnomAD
rs1272649511
CA348387811
594 Q>* No ClinGen
TOPMed
CA1858178
rs766998168
594 Q>R No ClinGen
ExAC
gnomAD
CA55325419
rs778751078
603 N>S No ClinGen
gnomAD
CA55325435
rs778751078
603 N>T No ClinGen
gnomAD
rs765199734
CA1858175
603 N>Y No ClinGen
ExAC
gnomAD
CA1858174
rs539101457
604 T>S No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 605 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs776739054
CA1858173
607 I>V No ClinGen
ExAC
gnomAD
TCGA novel 608 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1449752433
CA348387704
609 K>R No ClinGen
TOPMed
gnomAD
CA348387705
rs1449752433
609 K>T No ClinGen
TOPMed
gnomAD
TCGA novel 612 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs373484527
CA1858158
613 T>S No ClinGen
ESP
ExAC
gnomAD
COSM1691015
CA1858157
rs139049289
614 S>L Variant assessed as Somatic; 0.0 impact. skin [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA55324336
rs139049289
614 S>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348387323
rs1385827451
618 P>L No ClinGen
gnomAD
rs1473837762
CA348387314
619 E>V No ClinGen
gnomAD
rs757293615
CA1858153
621 N>D No ClinGen
ExAC
gnomAD
rs753886932
CA1858152
629 H>L No ClinGen
ExAC
gnomAD
rs1488774317
CA348387168
630 G>S No ClinGen
gnomAD
CA1858151
rs764362224
631 G>S No ClinGen
ExAC
gnomAD
rs1393523547
CA348387137
632 S>F No ClinGen
TOPMed
CA348387124
rs1455728204
633 R>S No ClinGen
TOPMed
COSM203490
rs1174382080
CA348387118
634 R>C large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA1858149
rs775316471
634 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1460478816
CA348387105
635 Q>R No ClinGen
TOPMed
rs767273632
CA1858148
638 Q>R No ClinGen
ExAC
gnomAD
rs1427747564
CA348387018
642 R>Q No ClinGen
TOPMed
gnomAD
rs759338358
CA55324300
642 R>W No ClinGen
ExAC
gnomAD
rs1573939436
CA348387012
643 V>G No ClinGen
Ensembl
rs1342057472
CA348387017
643 V>M No ClinGen
gnomAD
rs1366074068
CA348387001
645 R>L No ClinGen
gnomAD
COSM1006171
rs1366074068
CA348387003
645 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs752950326
CA1858123
650 M>L No ClinGen
ExAC
gnomAD
rs201793642
CA1858122
652 A>S No ClinGen
1000Genomes
ExAC
gnomAD
CA1858121
rs375848554
654 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348386350
rs1573928112
656 N>S No ClinGen
Ensembl
CA1858120
rs766294536
657 A>T No ClinGen
ExAC
gnomAD
CA1858119
rs368498162
659 F>V No ClinGen
ESP
ExAC
gnomAD
CA1858118
rs772887980
660 Y>H No ClinGen
ExAC
gnomAD
rs1558947043
CA348386314
661 S>L No ClinGen
Ensembl
rs1353903104
CA348386293
665 Q>* No ClinGen
TOPMed
gnomAD
CA348386294
rs1353903104
665 Q>E No ClinGen
TOPMed
gnomAD
rs1426001505
CA348386277
667 T>K No ClinGen
TOPMed
gnomAD
CA55372398
rs375990467
673 S>L No ClinGen
ESP
TOPMed
gnomAD
CA1858114
rs768284835
674 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA348386215
rs1333056804
676 R>Q No ClinGen
TOPMed
rs922942314
CA55372397
RCV001305476
676 R>W No ClinGen
ClinVar
TOPMed
dbSNP
CA348386179
rs1193349659
681 V>A No ClinGen
gnomAD
CA348386176
rs1232856265
682 D>H No ClinGen
TOPMed
gnomAD
CA348386177
rs1232856265
682 D>N No ClinGen
TOPMed
gnomAD
rs746280448
CA1858112
684 G>V No ClinGen
ExAC
gnomAD
CA348386125
rs1332898410
688 K>N No ClinGen
TOPMed
CA348385810
rs1573925976
689 V>G No ClinGen
Ensembl
CA348385813
rs776272932
689 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA1858095
rs776272932
689 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA1858094
rs768246711
691 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs774621930
CA1858092
693 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA1858087
rs201806429
696 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1858088
rs770220564
696 M>V No ClinGen
ExAC
gnomAD
rs747285412
CA1858084
697 E>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA1858085
rs374262917
697 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348385762
rs1331558572
698 E>K No ClinGen
TOPMed
CA1858083
rs780088602
700 D>Y No ClinGen
ExAC
gnomAD
CA55370651
rs1023249904
703 F>L No ClinGen
TOPMed
rs767223129
CA55370657
703 F>S No ClinGen
Ensembl
CA1858077
rs760066564
706 K>E No ClinGen
ExAC
gnomAD
CA1858078
rs760066564
706 K>Q No ClinGen
ExAC
gnomAD
rs775232626
CA1858076
707 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs775232626
CA55370614
707 E>V No ClinGen
ExAC
TOPMed
gnomAD
CA1858074
rs558588910
710 Q>E No ClinGen
1000Genomes
ExAC
gnomAD
CA1858073
rs763315862
711 Q>* No ClinGen
ExAC
gnomAD
rs748634294
CA1858070
714 Q>E No ClinGen
ExAC
gnomAD
CA1858069
rs377323636
715 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs747001718
CA1858067
716 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs1573925783
CA348385632
717 L>R No ClinGen
Ensembl
CA348385625
rs1263512849
719 A>T No ClinGen
gnomAD
CA1858066
rs780327353
720 T>S No ClinGen
ExAC
TOPMed
gnomAD
CA55370536
rs867602958
724 A>V No ClinGen
Ensembl
CA348385588
rs1192130599
725 E>K No ClinGen
gnomAD
CA348385572
rs1454673438
727 E>K No ClinGen
gnomAD
CA55370502
rs944132286
727 E>V No ClinGen
TOPMed
CA348385561
rs1573925710
728 V>G No ClinGen
Ensembl
CA158830
RCV000120793
rs143140054
728 V>M No ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA348385558
rs1400016690
729 V>A No ClinGen
TOPMed
rs763891077
CA1858062
729 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA1858061
rs763891077
729 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs752084851
CA1858059
731 G>E No ClinGen
ExAC
gnomAD
CA348385541
rs1573925656
732 E>G No ClinGen
Ensembl
rs1323378956
CA348385527
734 G>S No ClinGen
gnomAD
rs1435459493
CA348385524
734 G>V No ClinGen
TOPMed
VAR_014344
CA1858057
RCV000940515
rs4150522
735 S>P No ClinGen
ClinVar
UniProt
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV000120794
rs587778276
RCV001854618
CA158833
736 R>I No ClinGen
ClinVar
dbSNP
gnomAD
rs587778276
CA348385516
736 R>T No ClinGen
gnomAD
rs773618141
CA1858056
737 S>A No ClinGen
ExAC
TOPMed
gnomAD
rs773618141
CA55370407
737 S>P No ClinGen
ExAC
TOPMed
gnomAD
CA348385496
rs1350655187
739 Q>R No ClinGen
TOPMed
CA348385478
rs1171070703
740 A>S No ClinGen
TOPMed
rs772307115
CA1858032
742 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA1858030
rs774730824
743 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs770995913
CA1858029
743 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA1858027
rs140023882
747 M>L No ClinGen
ESP
ExAC
gnomAD
CA55368992
rs140023882
747 M>V No ClinGen
ESP
ExAC
gnomAD
rs369468852
CA1858025
750 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA1858024
rs566082692
750 M>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs369468852
CA1858026
750 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA1858021
rs779748578
754 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs115312738
CA1858019
755 D>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA348385373
rs1210108802
757 V>E No ClinGen
TOPMed
rs764330927
CA1858018
759 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs141971239
CA1858016
760 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs761057040
CA1858017
760 E>G No ClinGen
ExAC
gnomAD
rs1190997884
CA348385344
761 Y>C No ClinGen
TOPMed
CA1858015
rs189511674
764 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs771245959
CA1858012
765 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA1858013
rs774571443
765 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs372094432
CA1858010
768 A>G No ClinGen
ESP
ExAC
gnomAD
rs372094432
CA158836
RCV000120795
RCV001854619
768 A>V No ClinGen
ClinVar
ESP
ExAC
dbSNP
gnomAD
rs769509766
CA1858009
769 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs1158741248
CA348385228
771 K>R No ClinGen
TOPMed
CA348385207
rs1558944942
772 H>Q No ClinGen
Ensembl
CA348385211
rs1243050277
772 H>R No ClinGen
gnomAD
rs114613120
CA1858008
775 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA348385175
rs1387571112
775 P>S No ClinGen
TOPMed
rs766592763
CA1858005
779 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs146427260
CA1858004
779 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs200411611
CA55368815
781 R>G No ClinGen
TOPMed
gnomAD
rs1573923864
CA348385097
781 R>K No ClinGen
Ensembl

2 associated diseases with P19447

[MIM: 610651]: Xeroderma pigmentosum complementation group B (XP-B)

An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. Some XP-B patients present features of Cockayne syndrome, including cachectic dwarfism, pigmentary retinopathy, ataxia, decreased nerve conduction velocities. The phenotype combining xeroderma pigmentosum and Cockayne syndrome traits is referred to as XP-CS complex. {ECO:0000269|PubMed:10447254, ECO:0000269|PubMed:16947863, ECO:0000269|PubMed:8304337}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 616390]: Trichothiodystrophy 2, photosensitive (TTD2)

A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. {ECO:0000269|PubMed:9012405}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. Some XP-B patients present features of Cockayne syndrome, including cachectic dwarfism, pigmentary retinopathy, ataxia, decreased nerve conduction velocities. The phenotype combining xeroderma pigmentosum and Cockayne syndrome traits is referred to as XP-CS complex. {ECO:0000269|PubMed:10447254, ECO:0000269|PubMed:16947863, ECO:0000269|PubMed:8304337}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. {ECO:0000269|PubMed:9012405}. Note=The disease is caused by variants affecting the gene represented in this entry.

5 regional properties for P19447

Type Name Position InterPro Accession
domain Helicase, C-terminal 542 - 702 IPR001650
domain Helicase/UvrB, N-terminal 315 - 470 IPR006935
domain Helicase superfamily 1/2, ATP-binding domain 312 - 492 IPR014001
domain ERCC3/RAD25/XPB helicase, C-terminal domain 496 - 738 IPR032438
domain Helicase XPB/Ssl2, N-terminal domain 76 - 201 IPR032830

Functions

Description
EC Number 3.6.4.12 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleotide-excision repair factor 3 complex One of several protein complexes involved in nucleotide-excision repair; possesses endodeoxynuclease and DNA helicase activities. In S. cerevisiae, it is composed of Rad2p and the core TFIIH-Ssl2p complex (core TFIIH is composed of Rad3p, Tfb1p, Tfb2p, Ssl1p, Tfb4p and Tfb5p. Note that Ssl2p is also called Rad25p).
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
transcription factor TFIID complex A complex composed of TATA binding protein (TBP) and TBP associated factors (TAFs); the total mass is typically about 800 kDa. Most of the TAFs are conserved across species. In TATA-containing promoters for RNA polymerase II (Pol II), TFIID is believed to recognize at least two distinct elements, the TATA element and a downstream promoter element. TFIID is also involved in recognition of TATA-less Pol II promoters. Binding of TFIID to DNA is necessary but not sufficient for transcription initiation from most RNA polymerase II promoters.
transcription factor TFIIH core complex The 7 subunit core of TFIIH that is a part of either the general transcription factor holo-TFIIH or the nucleotide-excision repair factor 3 complex. In S. cerevisiae/humans the complex is composed of: Ssl2/XPB, Tfb1/p62, Tfb2/p52, Ssl1/p44, Tfb4/p34, Tfb5/p8 and Rad3/XPD.
transcription factor TFIIH holo complex A complex that is capable of kinase activity directed towards the C-terminal Domain (CTD) of the largest subunit of RNA polymerase II and is essential for initiation at RNA polymerase II promoters in vitro. It is composed of the core TFIIH complex and the TFIIK complex.
transcription preinitiation complex A protein-DNA complex composed of proteins binding promoter DNA to form the transcriptional preinitiation complex (PIC), the formation of which is a prerequisite for transcription.

8 GO annotations of molecular function

Name Definition
3'-5' DNA helicase activity Unwinding a DNA helix in the direction 5' to 3', driven by ATP hydrolysis.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
damaged DNA binding Binding to damaged DNA.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
promoter-specific chromatin binding Binding to a section of chromatin that is associated with gene promoter sequences of DNA.
protein C-terminus binding Binding to a protein C-terminus, the end of a peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
protein N-terminus binding Binding to a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.

19 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
DNA repair The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
DNA topological change The process in which a transformation is induced in the topological structure of a double-stranded DNA helix, resulting in a change in linking number.
embryonic organ development Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
hair cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a hair cell.
nucleotide-excision repair A DNA repair process in which a small region of the strand surrounding the damage is removed from the DNA helix as an oligonucleotide. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase. Nucleotide excision repair recognizes a wide range of substrates, including damage caused by UV irradiation (pyrimidine dimers and 6-4 photoproducts) and chemicals (intrastrand cross-links and bulky adducts).
nucleotide-excision repair, DNA duplex unwinding The unwinding, or local denaturation, of the DNA duplex to create a bubble around the site of the DNA damage.
nucleotide-excision repair, DNA incision A process that results in the endonucleolytic cleavage of the damaged strand of DNA. The incision occurs at the junction of single-stranded DNA and double-stranded DNA that is formed when the DNA duplex is unwound.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
protein localization Any process in which a protein is transported to, or maintained in, a specific location.
regulation of mitotic cell cycle phase transition Any process that modulates the frequency, rate or extent of mitotic cell cycle phase transition.
response to hypoxia Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
response to oxidative stress Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
response to UV Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
transcription by RNA polymerase II The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
transcription elongation by RNA polymerase II promoter The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II.
transcription initiation at RNA polymerase II promoter A transcription initiation process that takes place at a RNA polymerase II gene promoter. Messenger RNAs (mRNA) genes, as well as some non-coding RNAs, are transcribed by RNA polymerase II.
transcription-coupled nucleotide-excision repair The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway.
UV protection Any process in which an organism or cell protects itself from ultraviolet radiation (UV), which may also result in resistance to repeated exposure to UV.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q38861 XPB1 General transcription and DNA repair factor IIH helicase subunit XPB1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MGKRDRADRD KKKSRKRHYE DEEDDEEDAP GNDPQEAVPS AAGKQVDESG TKVDEYGAKD
70 80 90 100 110 120
YRLQMPLKDD HTSRPLWVAP DGHIFLEAFS PVYKYAQDFL VAIAEPVCRP THVHEYKLTA
130 140 150 160 170 180
YSLYAAVSVG LQTSDITEYL RKLSKTGVPD GIMQFIKLCT VSYGKVKLVL KHNRYFVESC
190 200 210 220 230 240
HPDVIQHLLQ DPVIRECRLR NSEGEATELI TETFTSKSAI SKTAESSGGP STSRVTDPQG
250 260 270 280 290 300
KSDIPMDLFD FYEQMDKDEE EEEETQTVSF EVKQEMIEEL QKRCIHLEYP LLAEYDFRND
310 320 330 340 350 360
SVNPDINIDL KPTAVLRPYQ EKSLRKMFGN GRARSGVIVL PCGAGKSLVG VTAACTVRKR
370 380 390 400 410 420
CLVLGNSAVS VEQWKAQFKM WSTIDDSQIC RFTSDAKDKP IGCSVAISTY SMLGHTTKRS
430 440 450 460 470 480
WEAERVMEWL KTQEWGLMIL DEVHTIPAKM FRRVLTIVQA HCKLGLTATL VREDDKIVDL
490 500 510 520 530 540
NFLIGPKLYE ANWMELQNNG YIAKVQCAEV WCPMSPEFYR EYVAIKTKKR ILLYTMNPNK
550 560 570 580 590 600
FRACQFLIKF HERRNDKIIV FADNVFALKE YAIRLNKPYI YGPTSQGERM QILQNFKHNP
610 620 630 640 650 660
KINTIFISKV GDTSFDLPEA NVLIQISSHG GSRRQEAQRL GRVLRAKKGM VAEEYNAFFY
670 680 690 700 710 720
SLVSQDTQEM AYSTKRQRFL VDQGYSFKVI TKLAGMEEED LAFSTKEEQQ QLLQKVLAAT
730 740 750 760 770 780
DLDAEEEVVA GEFGSRSSQA SRRFGTMSSM SGADDTVYME YHSSRSKAPS KHVHPLFKRF
RK